CEO of Guardant Health Inc (30-Year Financial, Insider Trades) Helmy Eltoukhy (insider trades) sold 253,699 shares of GH on 08/16/2019 at an average price of $100.21 a share. The total sale was $25.4 million.
Guardant Health Inc has a market cap of $9.44 billion; its shares were traded at around $101.52 with and P/S ratio of 78.03. GuruFocus has detected 1 severe warning sign with Guardant Health Inc. .
CEO Recent Trades:
- CEO Helmy Eltoukhy sold 253,699 shares of GH stock on 08/16/2019 at the average price of $100.21. The price of the stock has increased by 1.31% since.
- CEO Helmy Eltoukhy sold 426,301 shares of GH stock on 08/13/2019 at the average price of $99.58. The price of the stock has increased by 1.95% since.
Directors and Officers Recent Trades:
- Chief Medical Officer Richard B. Lanman sold 63,075 shares of GH stock on 08/09/2019 at the average price of $105.25. The price of the stock has decreased by 3.54% since.
- Director Ian T Clark sold 9,683 shares of GH stock on 08/06/2019 at the average price of $89.75. The price of the stock has increased by 13.11% since.
For the complete insider trading history of GH, click here
.This article first appeared on GuruFocus.
- Warning! GuruFocus has detected 3 Warning Sign with GH. Click here to check it out.
- GH 15-Year Financial Data
- The intrinsic value of GH
- Peter Lynch Chart of GH